A prospective trial to evaluate safety and efficacy of estrogen therapy in multiple formulations in menopausal women

Trial Profile

A prospective trial to evaluate safety and efficacy of estrogen therapy in multiple formulations in menopausal women

Planning
Phase of Trial: Phase I/II

Latest Information Update: 26 May 2016

At a glance

  • Drugs Estrogen
  • Indications Menopausal syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 May 2016 New trial record
    • 10 Feb 2016 According to a Viramal media release, the company has planned 6 studies in women's health including phase I/II, expected to initiate between Q2 2016 and 2017, subject to funding. The company is in the process of finalizing INDs for the drugs, including products to treat infertility in women with endometriosis and limit side effects of existing therapies, and provide estrogen therapy in multiple formulations for menopausal women.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top